Genomic Health Inc
Find Ratings Reports
-1.1 |
-3.3%
Below is a summary of the major fundamental and technical factors we consider when determining our overall recommendation of GHDX shares. It is provided in order to give you a deeper understanding of our rating methodology as well as to paint a more complete picture of a stock's strengths and weaknesses. It is important to note, however, that these factors only tell part of the story. To gain an even more comprehensive understanding of our stance on the stock, these factors must be assessed in combination with the stock’s valuation. Please refer to the Financial Analysis page for further information.
| Factor | Score | Rating |
|---|---|---|
| Growth | 2.0 out of 5 stars | |
Measures the growth of both the company's income statement and cash flow. On this factor, GHDX has a growth score better than 30% of the stocks we rate. | ||
| Total Return | 4.5 out of 5 stars | |
Measures the historical price movement of the stock. The stock performance of this company has beaten 80% of the companies we cover. | ||
| Efficiency | 1.0 out of 5 stars | |
Measures the strength and historic growth of a company's return on invested capital. The company has generated more income per dollar of capital than 10% of the companies we review. | ||
| Price Volatility | 3.5 out of 5 stars | |
Measures the volatility of the company's stock price historically. The stock is less volatile than 60% of the stocks we monitor. | ||
| Solvency | 2.5 out of 5 stars | |
Measures the solvency of the company based on several ratios. The company is more solvent than 40% of the companies we analyze. | ||
| Income | 0.5 out of 5 stars | |
Measures dividend yield and payouts to shareholders. This company pays no dividends. | ||
TheStreet Ratings' stock model projects a stock's total return potential over a 12-month period including both price appreciation and dividends. Our Buy, Hold or Sell ratings designate how we expect these stocks to perform against a general benchmark of the equities market and interest rates. While our model is quantitative, it utilizes both subjective and objective elements. For instance, subjective elements include expected equities market returns, future interest rates, implied industry outlook and forecasted company earnings. Objective elements include volatility of past operating revenues, financial strength, and company cash flows.
Our model guages the relationship between risk and reward in several ways, including: the pricing drawdown as ocmpared to potential profit volatility, i.e. how much one is willing to risk in order to earn profits; the level of acceptable volatility for highly performing stocks; the current valuation as compared to projected earnings growth; and the financial strength of the underlying company as compared to its stock's valuation as compared to its stock's performance. These and many more derived observations are then combined, ranked, weighted, and scenario-tested to create a more complete analysis. The result is a systematic and disciplined method of selecting stocks.
